Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B

We investigated the relationship between hepatitis B virus surface antigen (HBsAg) serum level decline and posttreatment response in patients with hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B from a large multinational study of pegylated interferon alfa‐2a (peginterferon alfa‐2a), with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2009-04, Vol.49 (4), p.1141-1150
Hauptverfasser:	Brunetto, Maurizia Rossana, Moriconi, Francesco, Bonino, Ferruccio, Lau, George K. K., Farci, Patrizia, Yurdaydin, Cihan, Piratvisuth, Teerha, Luo, Kangxian, Wang, Yuming, Hadziyannis, Stephanos, Wolf, Eva, McCloud, Philip, Batrla, Richard, Marcellin, Patrick
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - therapeutic use DNA, Viral - blood Drug Therapy, Combination Female Hepatitis B Surface Antigens - blood Hepatitis B virus - genetics Hepatitis B, Chronic - drug therapy Hepatitis B, Chronic - immunology Humans Interferon-alpha - therapeutic use Lamivudine - therapeutic use Male Middle Aged Polyethylene Glycols - therapeutic use Randomized Controlled Trials as Topic Recombinant Proteins Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!